Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cruickshank

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Surgical Neurology|February 1, 1986
Beta-blockers, plasma total creatine kinase and creatine kinase myocardial isoenzyme, and the prognosis of subarachnoid hemorrhageG Neil-Dwyer, J Cruickshank, C Stratton
Clinical Radiology|September 1, 1982
Antenatal detection of recurrence of Majewski dwarf (short rib-polydactyly syndrome type II Majewski)G S Thomson, C P Reynolds, J Cruickshank
British Journal of Obstetrics and Gynaecology|July 1, 1987
The clinical significance of pre-operative serum CA 125 in ovarian cancerD J Cruickshank, W T Fullerton, A Klopper
EPJ Data Science|April 25, 2022
Mapping state-sponsored information operations with multi-view modularity clusteringJoshua Uyheng, Iain J Cruickshank, Kathleen M Carley
Gynecologic Oncology|September 10, 2002
Does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?Paul M Flynn, Jim Paul, Derek J Cruickshank, et al.
Progress in Clinical and Biological Research|January 1, 1984
Intravesical chemotherapy--other agentsP H Smith, J Cruickshank, J W Hetherington
The British Journal of Nutrition|September 1, 1992
The intake, digestion and protein degradation of grazed herbage by early-weaned lambsG J Cruickshank, D P Poppi, A R Sykes
The International Journal of Biological Markers|October 1, 1991
The potential value of CA125 as a tumour marker in small volume, non-evaluable epithelial ovarian cancerD J Cruickshank, P B Terry, W T Fullerton
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 11, 2005
The role of routine follow-up after gynecological malignancyF M Kew, A P Roberts, D J Cruickshank
Lancet (London, England)|February 25, 1989
Vaginal endosonography in endometrial cancerD J Cruickshank, J M Randall, I D Miller
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Surgical Neurology|February 1, 1986
Beta-blockers, plasma total creatine kinase and creatine kinase myocardial isoenzyme, and the prognosis of subarachnoid hemorrhageG Neil-Dwyer, J Cruickshank, C Stratton
Clinical Radiology|September 1, 1982
Antenatal detection of recurrence of Majewski dwarf (short rib-polydactyly syndrome type II Majewski)G S Thomson, C P Reynolds, J Cruickshank
British Journal of Obstetrics and Gynaecology|July 1, 1987
The clinical significance of pre-operative serum CA 125 in ovarian cancerD J Cruickshank, W T Fullerton, A Klopper
EPJ Data Science|April 25, 2022
Mapping state-sponsored information operations with multi-view modularity clusteringJoshua Uyheng, Iain J Cruickshank, Kathleen M Carley
Gynecologic Oncology|September 10, 2002
Does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?Paul M Flynn, Jim Paul, Derek J Cruickshank, et al.
Progress in Clinical and Biological Research|January 1, 1984
Intravesical chemotherapy--other agentsP H Smith, J Cruickshank, J W Hetherington
The British Journal of Nutrition|September 1, 1992
The intake, digestion and protein degradation of grazed herbage by early-weaned lambsG J Cruickshank, D P Poppi, A R Sykes
The International Journal of Biological Markers|October 1, 1991
The potential value of CA125 as a tumour marker in small volume, non-evaluable epithelial ovarian cancerD J Cruickshank, P B Terry, W T Fullerton
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 11, 2005
The role of routine follow-up after gynecological malignancyF M Kew, A P Roberts, D J Cruickshank
Lancet (London, England)|February 25, 1989
Vaginal endosonography in endometrial cancerD J Cruickshank, J M Randall, I D Miller
Pageof 11